- Home
- » Tags
- » Vabicaserin
Top View
- Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
- (12) United States Patent (10) Patent No.: US 9,517,254 B2 Sitchon Et Al
- Acetic Acid 26, 254, 279, 289, 290, 316, 425, 446 Acetonitrile 47, 93
- Pharmaabkommen A1 E
- (12) United States Patent (10) Patent No.: US 8,748,419 B2 Seed Et Al
- Possible Molecular Mediators Involved and Mechanistic Insight Into Fibromyalgia and Associated Co‑Morbidities
- © Copyright 2017 Ryan P. Seguin
- Bioactive Compound Library Plus (96-Well)
- 5-HT Receptor Serotonin Receptor; 5-Hydroxytryptamine Receptor
- Poster Session Iiiwednesday, December 9, 2015
- Flow Photochemistry Fabrizio Politano, and Gabriela Oksdath-Mansilla Org
- Potentiel Thérapeutique De JJ-3-42, Un Nouvel Agoniste Sélectif Des Récepteurs 5-HT2C, Dans Le Traitement Des Maladies Psychiatriques
- Download Poster
- I Fakultät Für Medizin Klinik Und Poliklinik Für Psychiatrie Und
- Drug Repurposing Compound Library Plus (96-Well)
- (12) United States Patent (10) Patent No.: US 9,169,213 B2 Sanchez Et Al
- Recommendations for the Treatment of Schizophrenia with Negative Symptoms
- A Decade in the MIST: Learnings from Investigations of Drug Metabolites in Drug Development Under the “Metabolites in Safety Testing” Regulatory Guidance
- Neuronal Signaling
- Lorcaserin As a Potential Opioid-Sparing Adjunct
- Learning from the Past and Looking to the Future Emerging Perspectives
- Discovery of N‑Substituted (2-Phenylcyclopropyl)Methylamines
- Developing Tomorrow's Antipsychotics
- Nuevas Perspectivas En Farmacoterapia De La Obesidad
- Poster Session I 2
- (12) United States Patent (10) Patent No.: US 9,045,498 B2 Brodney Et Al
- Synthesis and Biological Evaluation of Disubstituted Pyrimidines As Selective 5-HT2C Agonists
- ( 12 ) United States Patent
- Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
- 23-1-2017 a Short History of the 5
- Metformin and Lorcaserin for Weight Loss in People with Schizophrenia (MELT)
- (12) United States Patent (10) Patent No.: US 8,778,960 B2 Deaver Et Al
- Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases
- Therapeutic Potential of 5-HT2C Receptor Ligands